Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder

View ORCID ProfileKheireddin Mufti, View ORCID ProfileEric Yu, View ORCID ProfileUladzislau Rudakou, View ORCID ProfileLynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Isabelle Arnulf, View ORCID ProfileMichele T.M. Hu, Jacques Y. Montplaisir, Jean-François Gagnon, Alex Desautels, Yves Dauvilliers, View ORCID ProfileGian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Andrea Bernardini, Birgit Högl, View ORCID ProfileAmbra Stefani, View ORCID ProfileEvi Holzknecht, View ORCID ProfileKarel Sonka, View ORCID ProfileDavid Kemlink, View ORCID ProfileWolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Michela Figorilli, View ORCID ProfileMonica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Döring, Valérie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Jean-François Trempe, View ORCID ProfileGuy A. Rouleau, Ronald B. Postuma, View ORCID ProfileZiv Gan-Or
doi: https://doi.org/10.1101/2020.06.27.20140350
Kheireddin Mufti
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kheireddin Mufti
Eric Yu
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Yu
Uladzislau Rudakou
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Uladzislau Rudakou
Lynne Krohn
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lynne Krohn
Jennifer A. Ruskey
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farnaz Asayesh
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra B. Laurent
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Spiegelman
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Arnulf
4Sleep Disorders Unit, Pitié Salpêtrière Hospital, Paris Brain Institute and Sorbonne University, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele T.M. Hu
5Oxford Parkinson’s Disease Centre (OPDC), University of Oxford, Oxford, United Kingdom
6Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michele T.M. Hu
Jacques Y. Montplaisir
7Center for Advanced Research in Sleep Medicine, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal – Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada
8Department of Psychiatry, Université de Montréal, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-François Gagnon
7Center for Advanced Research in Sleep Medicine, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal – Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada
9Department of Psychology, Université du Québec à Montréal, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Desautels
7Center for Advanced Research in Sleep Medicine, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal – Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada
10Department of Neurosciences, Université de Montréal, Montréal, QC, H3T 1J4, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yves Dauvilliers
11National Reference Center for Narcolepsy, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Inserm U1061, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gian Luigi Gigli
12Clinical Neurology Unit, Department of Neurosciences, University Hospital of Udine, Udine, Italy
13DMIF, University of Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gian Luigi Gigli
Mariarosaria Valente
12Clinical Neurology Unit, Department of Neurosciences, University Hospital of Udine, Udine, Italy
14Department of Medicine (DAME), University of Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Janes
12Clinical Neurology Unit, Department of Neurosciences, University Hospital of Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Bernardini
12Clinical Neurology Unit, Department of Neurosciences, University Hospital of Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Birgit Högl
15Sleep Disorders Clinic, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ambra Stefani
15Sleep Disorders Clinic, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ambra Stefani
Evi Holzknecht
15Sleep Disorders Clinic, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evi Holzknecht
Karel Sonka
16Department of Neurology and Centre of Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karel Sonka
David Kemlink
16Department of Neurology and Centre of Clinical Neuroscience, Charles University, First Faculty of Medicine and General University Hospital, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Kemlink
Wolfgang Oertel
17Department of Neurology, Philipps University, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wolfgang Oertel
Annette Janzen
17Department of Neurology, Philipps University, Marburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Plazzi
18Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio-Emilia, Modena, Italy
19IRCCS, Institute of Neurological Sciences of Bologna, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Antelmi
20Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michela Figorilli
21Department of Medical Sciences and Public Health, Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Puligheddu
21Department of Medical Sciences and Public Health, Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Monica Puligheddu
Brit Mollenhauer
22Paracelsus-Elena-Klinik, Kassel, Germany
23Department of Neurosurgery, University Medical Centre Göttingen, Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Trenkwalder
22Paracelsus-Elena-Klinik, Kassel, Germany
23Department of Neurosurgery, University Medical Centre Göttingen, Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friederike Sixel-Döring
17Department of Neurology, Philipps University, Marburg, Germany
22Paracelsus-Elena-Klinik, Kassel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valérie Cochen De Cock
24Sleep and Neurology Unit, Beau Soleil Clinic, Montpellier, France
25EuroMov Digital Health in Motion, University of Montpellier IMT Mines Ales, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christelle Charley Monaca
26University Lille North of France, Department of Clinical Neurophysiology and Sleep Center, CHU Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Heidbreder
27Department of Sleep Medicine and Neuromuscular Disorders, University of Müenster, Müenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Ferini-Strambi
28Department of Neurological Sciences, Università Vita-Salute San Raffaele, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Femke Dijkstra
29Laboratory for Sleep Disorders, St. Dimpna Regional Hospital, Geel, Belgium
30Department of Neurology, St. Dimpna Regional Hospital, Geel, Belgium
31Department of Neurology, University Hospital Antwerp, Edegem, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mineke Viaene
29Laboratory for Sleep Disorders, St. Dimpna Regional Hospital, Geel, Belgium
30Department of Neurology, St. Dimpna Regional Hospital, Geel, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz Abril
32Sleep disorder Unit, Carémeau Hospital, University Hospital of Nîmes, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley F. Boeve
33Department of Neurology, Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-François Trempe
34Centre de Recherche en Biologie Structurale and Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy A. Rouleau
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guy A. Rouleau
Ronald B. Postuma
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
7Center for Advanced Research in Sleep Medicine, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal – Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
1Department of Human Genetics, McGill University, Montréal, QC, Canada
2Montreal Neurological Institute, McGill University, Montréal, QC, Canada
3Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ziv Gan-Or
  • For correspondence: ziv.gan-or@mcgill.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To examine the role of genes identified through genome-wide association studies (GWASs) of Parkinson disease (PD) in the risk of isolated rapid-eye-movement (REM) sleep behavior disorder (iRBD).

Methods We fully sequenced 25 genes previously identified in GWASs of PD, in a total of 1,039 iRBD patients and 1,852 controls. The role of rare heterozygous variants in these genes was examined using burden tests. The contribution of biallelic variants was further tested. To examine the potential impact of rare nonsynonymous BST1 variants on the protein structure, we performed in silico structural analysis. Finally, we examined the association of common variants using logistic regression adjusted for age and sex.

Results We found an association between rare heterozygous nonsynonymous variants in BST1 and iRBD (p=0.0003 at coverage >50X and 0.0004 at >30X), mainly driven by three nonsynonymous variants (p.V85M, p.I101V and p.V272M) found in 22 (1.2%) controls vs. two (0.2%) patients. All three variants seem to be loss-of-function variants with a potential effect on the protein structure and stability. Rare non-coding heterozygous variants in LAMP3 were also associated with iRBD (p=0.0006 at >30X). We found no association between rare heterozygous variants in the rest of genes and iRBD. Several carriers of biallelic variants were identified, yet there was no overrepresentation in iRBD.

Conclusion Our results suggest that rare coding variants in BST1 and rare non-coding variants in LAMP3 are associated with iRBD. Additional studies are required to replicate these results and examine whether loss-of-function of BST1 could be a therapeutic target.

Competing Interest Statement

Kheireddin Mufti - Reports no conflict of interest to disclose. Eric Yu - Reports no conflict of interests to disclose. Uladislau Rudakou - Reports no conflict of interests to disclose. Lynne Krohn - Reports no conflict of interests to disclose. Jennifer A. Ruskey -Reports no conflict of interests to disclose. Farnaz Asayesh - Reports no conflict of interests to disclose. Sandra B. Laurent - Reports no conflict of interests to disclose. Dan Spiegelman - Reports no conflict of interests to disclose. Isabelle Arnulf - Received fees for speaking engagements from UCB pharma, consultancy for Roche, Novartis, and Ono Pharma. Michele T.M. Hu - Received consultancy fees from Roche and Biogen Pharmaceuticals. Jacques Y. Montplaisir - Received consultancy fees from Eisai Co. Jean-François Gagnon - Reports research funding from the Canadian Institutes of Health Research (CIHR). Alex Desautels - Received grants from Flamel Ireland, Pfized, Biron, Canopy Growth, as well as fees for speaking engagements from Biogen and from consultancy from UCB pharma. Yves Dauvilliers - Reports no conflict of interests to disclose. Gian Luigi Gigli - Reports no conflict of interests to disclose. Mariarosaria Valente - Reports no conflict of interests to disclose. Francesco Janes - Reports no conflict of interests to disclose. Andrea Bernardini - Reports no conflict of interests to disclose. Birgit Högl - Received consultancy fees from Axovant, benevolent Bio, Takeda, Roche, ono, and received speaker honoraria from Eli Lilly, Mundipharma, UCB, Abbvie, Inspire, Lundbeck. Ambra Stefani - Reports no conflict of interests to disclose. Evi Holzknecht - Reports no conflict of interests to disclose. Karel Sonka - Reports no conflict of interests to disclose. David Kemlink - Reports no conflict of interests to disclose. Wolfgang Oertel - Reports no conflict of interests related to the study. He received consultancy or speaker fees from Adamas, Abbvie, Desitin, Novartis and Roche. He has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung and Roche Pharma, Basel, Switzerland. Annette Janzen - Reports no conflict of interests to disclose. She has received research funding from Parkinson Fonds Deutschland. Giuseppe Plazzi - Reports no conflict of interests to disclose. Elena Antelmi - Reports no conflict of interests to disclose. Michela Figorilli - Reports no conflict of interests to disclose. Monica Puligheddu - Reports no conflict of interests to disclose. Brit Mollenhauer - Has received honoraria for consultancy from Roche, Biogen, UCB and Sun Pharma Advanced Research Company. BM is member of the executive steering committee of the Parkinson Progression Marker Initiative and PI of the Systemic Synuclein Sampling Study of the Michael J. Fox Foundation for Parkinson's Research and has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung and the Michael J. Fox Foundation for Parkinson's Research. Claudia Trenkwalder - Honoraria for lectures from UCB, Grünenthal, Otsuka and consultancy fees from Britannia Pharmaceuticals and Roche. Friederike Sixel-Döring - Honoraria for lectures from Abbott, Desitin, Grünenthal, Licher MT, STADA Pharm, UCB. Seminar fees from Boston Scientific, Licher MT. Serves on an advisory board for STADA Pharm. No conflict of interest with the presented study. Valérie Cochen De Cock - Reports no conflict of interests to disclose. Christelle Charley Monaca - Reports no conflict of interests to disclose. Anna Heidbreder - Reports no conflict of interests to disclose. Luigi Ferini-Strambi - Reports no conflict of interests to disclose. Femke Dijkstra - Reports no conflict of interests to disclose. Mineke Viaene - Reports no conflict of interests to disclose. Beatriz Abril - Reports no conflict of interests to disclose. Bradley F. Boeve - Dr. Boeve has served as an investigator for clinical trials sponsored by Biogen and Alector. He serves on the Scientific Advisory Board of the Tau Consortium. He receives research support from the NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the LBD Functional Genomics Program. Jean-François Trempe - Reports no conflict of interests to disclose. Guy A. Rouleau - Reports no conflict of interests to disclose. Ronald B. Postuma - Reports grants and Fonds de la Recherche en Sante, as well as grants from the Canadian Institute of Health Research, The Parkinson Society of Canada, the WestonGarfield Foundation, the Michael J. Fox Foundation, and the Webster Foundation, as well as personal fees from Takeda, Roche, Teva Neurosciences, Novartis Canada, Biogen, Boehringer Ingelheim, Theranexus, GE HealthCare, Jazz Pharmaceuticals, Abbvie, Jannsen, Otsuko, Phytopharmics, and Inception Sciences. Ziv Gan-Or - Received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Ono Therapeutics, Denali, Handl Therapeutics, Neuron23 and Deerfield.

Funding Statement

This work was financially supported by the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), Parkinson Canada the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives (HBHL) program. The Montreal cohort was funded by the Canadian Institutes of Health Research (CIHR) and the W. Garfield Weston Foundation. The Oxford Discovery study is funded by the Monument Trust Discovery Award from Parkinson's UK and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, the NIHR Clinical Research Network and the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study participants signed informed consent forms at enrollment to the study, and the Research Ethics Office (Institutional Review Board) of McGill University has approved the study protocol.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Statistical review: Ziv Gan-Or

  • Study funding: This work was financially supported by the Michael J. Fox Foundation, the Canadian Consortium on Neurodegeneration in Aging (CCNA), Parkinson Canada the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives (HBHL) program. The Montreal cohort was funded by the Canadian Institutes of Health Research (CIHR) and the W. Garfield Weston Foundation. The Oxford Discovery study is funded by the Monument Trust Discovery Award from Parkinson’s UK and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, the NIHR Clinical Research Network and the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN).

  • Disclosures: Kheireddin Mufti – Reports no conflict of interest to disclose.

    Eric Yu - Reports no conflict of interests to disclose.

    Uladislau Rudakou - Reports no conflict of interests to disclose.

    Lynne Krohn – Reports no conflict of interests to disclose.

    Jennifer A. Ruskey – Reports no conflict of interests to disclose. Farnaz Asayesh – Reports no conflict of interests to disclose.

    Sandra B. Laurent – Reports no conflict of interests to disclose.

    Dan Spiegelman – Reports no conflict of interests to disclose.

    Isabelle Arnulf – Received fees for speaking engagements from UCB pharma, consultancy for Roche, Novartis, and Ono Pharma.

    Michele T.M. Hu – Received consultancy fees from Roche and Biogen Pharmaceuticals.

    Jacques Y. Montplaisir – Received consultancy fees from Eisai Co.

    Jean-François Gagnon – Reports research funding from the Canadian Institutes of Health Research (CIHR).

    Alex Desautels – Received grants from Flamel Ireland, Pfized, Biron, Canopy Growth, as well as fees for speaking engagements from Biogen and from consultancy from UCB pharma.

    Yves Dauvilliers – Reports no conflict of interests to disclose.

    Gian Luigi Gigli – Reports no conflict of interests to disclose.

    Mariarosaria Valente – Reports no conflict of interests to disclose. Francesco Janes - Reports no conflict of interests to disclose.

    Andrea Bernardini - Reports no conflict of interests to disclose.

    Birgit Högl – Received consultancy fees from Axovant, benevolent Bio, Takeda, Roche, ono, and received speaker honoraria from Eli Lilly, Mundipharma, UCB, Abbvie, Inspire, Lundbeck.

    Ambra Stefani – Reports no conflict of interests to disclose.

    Evi Holzknecht – Reports no conflict of interests to disclose.

    Karel Sonka – Reports no conflict of interests to disclose.

    David Kemlink – Reports no conflict of interests to disclose.

    Wolfgang Oertel – Reports no conflict of interests related to the study. He received consultancy or speaker fees from Adamas, Abbvie, Desitin, Novartis and Roche. He has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung and Roche Pharma, Basel, Switzerland.

    Annette Janzen – Reports no conflict of interests to disclose. She has received research funding from Parkinson Fonds Deutschland.

    Giuseppe Plazzi – Reports no conflict of interests to disclose.

    Elena Antelmi – Reports no conflict of interests to disclose.

    Michela Figorilli – Reports no conflict of interests to disclose.

    Monica Puligheddu – Reports no conflict of interests to disclose.

    Brit Mollenhauer – Has received honoraria for consultancy from Roche, Biogen, UCB and Sun Pharma Advanced Research Company. BM is member of the executive steering committee of the Parkinson Progression Marker Initiative and PI of the Systemic Synuclein Sampling Study of the Michael J. Fox Foundation for Parkinson’s Research and has received research funding from the Deutsche Forschungsgemeinschaft (DFG), EU (Horizon2020), Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung and the Michael J. Fox Foundation for Parkinson’s Research.

    Claudia Trenkwalder – Honoraria for lectures from UCB, Grünenthal, Otsuka and consultancy fees from Britannia Pharmaceuticals and Roche.

    Friederike Sixel-Döring – Honoraria for lectures from Abbott, Desitin, Grünenthal, Licher MT, STADA Pharm, UCB. Seminar fees from Boston Scientific, Licher MT. Serves on an advisory board for STADA Pharm. No conflict of interest with the presented study.

    Valérie Cochen De Cock – Reports no conflict of interests to disclose.

    Christelle Charley Monaca – Reports no conflict of interests to disclose.

    Anna Heidbreder – Reports no conflict of interests to disclose.

    Luigi Ferini-Strambi – Reports no conflict of interests to disclose.

    Femke Dijkstra – Reports no conflict of interests to disclose.

    Mineke Viaene – Reports no conflict of interests to disclose.

    Beatriz Abril – Reports no conflict of interests to disclose.

    Bradley F. Boeve – Dr. Boeve has served as an investigator for clinical trials sponsored by Biogen and Alector. He serves on the Scientific Advisory Board of the Tau Consortium. He receives research support from the NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the LBD Functional Genomics Program.

    Jean-François Trempe – Reports no conflict of interests to disclose.

    Guy A. Rouleau – Reports no conflict of interests to disclose.

    Ronald B. Postuma – Reports grants and Fonds de la Recherche en Sante, as well as grants from the Canadian Institute of Health Research, The Parkinson Society of Canada, the WestonGarfield Foundation, the Michael J. Fox Foundation, and the Webster Foundation, as well as personal fees from Takeda, Roche, Teva Neurosciences, Novartis Canada, Biogen, Boehringer Ingelheim, Theranexus, GE HealthCare, Jazz Pharmaceuticals, Abbvie, Jannsen, Otsuko, Phytopharmics, and Inception Sciences.

    Ziv Gan-Or – Received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Ono Therapeutics, Denali, Handl Therapeutics, Neuron23 and Deerfield.

Data Availability

Data after processing that was used for the analyses in the current study are found in the supplementary tables, data available from Dryad (Table e-1 - e-7): https://doi.org/10.5061/dryad.vt4b8gtqd. The raw data can be requested from the corresponding author and will be shared anonymized.

  • Glossary

    AAO
    age at onset
    AAS
    age at sampling
    ACMSD
    Aminocarboxymuconate semialdehyde decarboxylase
    BST1
    Bone marrow stromal cell antigen 1
    CADD
    Combined Annotation Dependent Depletion
    CCDC62
    Coiled-coil domain containing 62
    CI
    confidence interval
    DOC
    depth of coverage
    F_A
    frequency in affected
    F_C
    frequency in control
    FGF20
    Fibroblast growth factor 20
    GAK
    Cyclin G associated kinase
    GATK
    Genome Analysis Toolkit
    GnomAD
    Genome Aggregation Database
    GPNMB
    Glycoprotein (transmembrane) nmb
    GTEx
    Genotype-tissue expression
    GWAS
    genome-wide association study
    hg19
    human genome version 19
    HIP1R
    Huntingtin interacting protein 1 related
    iRBD
    isolated rapid-eye-movement sleep behavior disorder
    ITGA8
    Integrin subunit alpha 8
    LAMP3
    Lysosomal-associated membrane protein 3
    LD
    linkage disequilibrium
    LOF
    loss-of-function
    MAF
    minor allele frequency
    MAPT
    Microtubule-associated protein tau
    MCCC1
    Methylcrotonoyl-CoA carboxylase 1 (α)
    MIPs
    molecular inversion probes
    NS
    non-synonymous
    OR
    odds ratio
    PCA
    principle component analysis
    PM20D1
    Peptidase M20 domain containing 1
    QC
    quality control
    QS
    quality score
    REM
    rapid eye movement
    RIT2
    Ras Like without CAAX 2
    SCARB2
    Scavenger receptor class B, member 2
    SETD1A
    SET domain containing 1A, histone lysine methyltransferase
    SIPA1L2
    Signal induced proliferation associated 1 like 2
    SKAT
    sequence kernel association test
    SKAT-O
    optimized SKAT
    SLC41A1
    Solute carrier family 41 (magnesium transporter), member 1
    STK39
    Serine/threonine kinase 39
    STX1B
    Syntaxin 1B
    SYT11
    Synaptotagmin 11
    TMEM163
    Transmembrane protein 163
    USP25
    Ubiquitin specific peptidase 25
    UTR
    untranslated region
    vPSG
    video polysomnography
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted October 26, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder
    Kheireddin Mufti, Eric Yu, Uladzislau Rudakou, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Isabelle Arnulf, Michele T.M. Hu, Jacques Y. Montplaisir, Jean-François Gagnon, Alex Desautels, Yves Dauvilliers, Gian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Andrea Bernardini, Birgit Högl, Ambra Stefani, Evi Holzknecht, Karel Sonka, David Kemlink, Wolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Michela Figorilli, Monica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Döring, Valérie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Jean-François Trempe, Guy A. Rouleau, Ronald B. Postuma, Ziv Gan-Or
    medRxiv 2020.06.27.20140350; doi: https://doi.org/10.1101/2020.06.27.20140350
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Novel associations of BST1 and LAMP3 with rapid eye movement sleep behavior disorder
    Kheireddin Mufti, Eric Yu, Uladzislau Rudakou, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Isabelle Arnulf, Michele T.M. Hu, Jacques Y. Montplaisir, Jean-François Gagnon, Alex Desautels, Yves Dauvilliers, Gian Luigi Gigli, Mariarosaria Valente, Francesco Janes, Andrea Bernardini, Birgit Högl, Ambra Stefani, Evi Holzknecht, Karel Sonka, David Kemlink, Wolfgang Oertel, Annette Janzen, Giuseppe Plazzi, Elena Antelmi, Michela Figorilli, Monica Puligheddu, Brit Mollenhauer, Claudia Trenkwalder, Friederike Sixel-Döring, Valérie Cochen De Cock, Christelle Charley Monaca, Anna Heidbreder, Luigi Ferini-Strambi, Femke Dijkstra, Mineke Viaene, Beatriz Abril, Bradley F. Boeve, Jean-François Trempe, Guy A. Rouleau, Ronald B. Postuma, Ziv Gan-Or
    medRxiv 2020.06.27.20140350; doi: https://doi.org/10.1101/2020.06.27.20140350

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (140)
    • Anesthesia (44)
    • Cardiovascular Medicine (404)
    • Dentistry and Oral Medicine (66)
    • Dermatology (47)
    • Emergency Medicine (141)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (168)
    • Epidemiology (4773)
    • Forensic Medicine (2)
    • Gastroenterology (173)
    • Genetic and Genomic Medicine (666)
    • Geriatric Medicine (69)
    • Health Economics (187)
    • Health Informatics (614)
    • Health Policy (312)
    • Health Systems and Quality Improvement (198)
    • Hematology (83)
    • HIV/AIDS (155)
    • Infectious Diseases (except HIV/AIDS) (5240)
    • Intensive Care and Critical Care Medicine (322)
    • Medical Education (88)
    • Medical Ethics (23)
    • Nephrology (72)
    • Neurology (674)
    • Nursing (41)
    • Nutrition (109)
    • Obstetrics and Gynecology (123)
    • Occupational and Environmental Health (203)
    • Oncology (435)
    • Ophthalmology (137)
    • Orthopedics (36)
    • Otolaryngology (88)
    • Pain Medicine (34)
    • Palliative Medicine (15)
    • Pathology (127)
    • Pediatrics (193)
    • Pharmacology and Therapeutics (128)
    • Primary Care Research (82)
    • Psychiatry and Clinical Psychology (757)
    • Public and Global Health (1786)
    • Radiology and Imaging (315)
    • Rehabilitation Medicine and Physical Therapy (135)
    • Respiratory Medicine (254)
    • Rheumatology (86)
    • Sexual and Reproductive Health (67)
    • Sports Medicine (59)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (28)
    • Urology (37)